Miguel J. A. Láinez

Author

Miguel J. A. Láinez

Hospital Clínico Universitario de Valencia ORCID

Also Known As

B Lacave, B. Lacave, Delgado, J., F. S. Mennini, J. Kushida, Kushida, J., Lainez, M., Lainez, Miguel J. A., Lamastra, A., Lapington, J.

151

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Clínico Universitario de Valencia Glostrup Hospital Universitat de València University of Pavia University of Duisburg-Essen

About

Miguel J. A. Láinez is an author at Hospital Clínico Universitario de Valencia specializing in medicine, neurology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.1K
2	Engineering	2	2	40
3	Health Sciences	2	2	155
4	Natural Sciences	2	2	40
5	Arts	1	1	333

Miguel J. A. Láinez

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Stratified Care vs Step Care Strategies for Migraine Richard B. Lipton, Walter F. Stewart, Andrew Stone, JAMA	2000	364
Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study Jean Schoenen, Rigmor Jensen, Michel Lantéri‐Minet, Cephalalgia	2013	345
Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006 Berthold Langguth, R. J. Goodey, Andréia Aparecida de Azevedo, Progress in brain research Treatment Outcome MeasurementPediatric OtolaryngologyTinnitusAudiologyOtolaryngology	2007	333
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial Wim M. Mulleners, Byung‐Kun Kim, Miguel J. A. Láinez, The Lancet Neurology Cluster HeadachePharmacologyClinical TrialsPharmacotherapyNeurology	2020	272
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study Hans‐Christoph Diener, Gilles Géraud, Miguel J. A. Láinez, The Lancet Neurology Acute TreatmentCluster HeadacheMedicineNeuropharmacologyPharmacotherapy	2012	186
Recommendations for headache service organisation and delivery in Europe Timothy J. Steiner, Fabio Antonaci, Rigmor Jensen, The Journal of Headache and Pain	2011	139
Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project) Lars Bendtsen, Cristina Tassorelli, Giuseppe Nappi, Cephalalgia	2013	138
A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study Cristina Tassorelli, Rigmor Jensen, Marta Allena, Cephalalgia	2014	131
Treatment options for subjective tinnitus: Self reports from a sample of general practitioners and ENT physicians within Europe and the USA Deborah A. Hall, Miguel J. A. Láinez, Craig W. Newman, BMC Health Services Research	2011	121
European Academy of Neurology guideline on the management of medication‐overuse headache Hans‐Christoph Diener, Fabio Antonaci, Mark Braschinsky, European Journal of Neurology	2020	118

Page 1